Telix Pharmaceuticals Ltd has released a press release.
Gozellix Receives Permanent HCPCS Code
Filed with ASX ·
Watch Telix Pharmaceuticals' latest callTelix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call · Replay · Aug 20Read the transcript of Telix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call6ix hasn’t read this filing yet.
Telix Pharmaceuticals Limited on 6ix
Earlier from Telix Pharmaceuticals
- Illuccix Approved in U.S. for Patient Selection for Pre-Taxane RLT
- Telix Precision Medicine Announces AlFluor Radiochemistry Platform
- Telix Theranostic Programs and Satellite Symposia on Innovation in PSMA and CAIX Imaging Featured at SNMMI 2025
- Telix Investor Day Presentation
- Telix Manufacturing Solutions (TMS) Established in Yokohama, Japan
Later from Telix Pharmaceuticals
- Telix Reports US$204M Q2 Revenue, Up 63% YOY
- Telix H1 2025 Results: Investor Webcast Notification
- Historical Financials in USD and H12025 OPEX (Unaudited)
- Telix H1 2025 Appendix 4D and Interim Report
- Telix H1 2025 Results Presentation
Follow Telix Pharmaceuticals into a list and get an email when it puts out news.
Follow Telix Pharmaceuticals